$IMMX Income Statement | Understand Stock

$IMMX

$8.05 -$0.01 (0.12%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating expenses:
General and administrative expenses
Research and development
Total operating expenses
Loss from operations
Other income:
Change in fair value of derivative liability
Loss on debt extinguishment
Interest income
Interest expense
Total other income

Loss before provision for income taxes
Provision for income taxes
Net loss
Net loss attributable to non-controlling interests
Net loss attributable to Immix Biopharma, Inc. common stockholders
Other comprehensive income (loss):
Foreign currency translation
Total other comprehensive income (loss)
Comprehensive loss
Comprehensive loss attributable to Immix Biopharma, Inc. common stockholders
Loss per common share - basic and diluted
Weighted average shares outstanding - basic and diluted

Loss per common share - basic
Loss per common share - diluted
Weighted average shares outstanding - basic
Weighted average shares outstanding - diluted

Comments